COMPASS Pathways plc (CMPS) Tops Q2 EPS by 11c

COMPASS Pathways plc (NASDAQ: CMPS) reported Q2 EPS of ($0.50), $0.11 better than the analyst estimate of ($0.61).

For earnings history and earnings-related data on COMPASS Pathways plc (CMPS) click here.

You May Also Be Interested In

• Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
• Wolfe Research on Compass Pathways (CMPS): 'we expect the stock to regain strong momentum after this pullback'
• Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'